Aarhus University at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
Aarhus University brings 4 presentations to ESGCT 2026 in Hamburg. Its work covers lipid nanoparticle and lentivirus-derived delivery for editing blood cells and the eye. One strand asks how the route of administration shapes nanoparticle delivery in acute myeloid leukaemia and how to transfect cryopreserved patient samples.
| Organization | ESGCT 2026 Attendance |
|---|---|
Aarhus University Aarhus, Denmark | |
Danish public research university with groups working on genome editing and gene delivery. | Talk Tue Oct 27 5:00pm–7:30pm SESSION 2b: (Epi)genome editing I Gene and epigenome editing Poster Thu Oct 29 2:00pm–4:00pm All Roads Lead to the Marrow: How Administration Route Shapes LNP Delivery in AML Poster Thu Oct 29 2:00pm–4:00pm Improving lipid nanoparticle transfection efficiency in cryopreserved primary acute myeloid leukemia patient samples Poster Thu Oct 29 2:00pm–4:00pm Next-generation lentivirus-derived nanoparticles mediate prime editing–based correction of pathogenic gene variants in the mouse eye and in human hematopoietic stem cells |
Instantly find 20 buyers from Aarhus University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction